The WACC of Middle East Healthcare Company PJSC (4009.SR) is 10.9%.
Range | Selected | |
Cost of equity | 12.20% - 15.00% | 13.60% |
Tax rate | 10.50% - 22.70% | 16.60% |
Cost of debt | 5.00% - 5.00% | 5.00% |
WACC | 10.0% - 11.9% | 10.9% |
Category | Low | High |
Long-term bond rate | 5.9% | 6.4% |
Equity market risk premium | 6.1% | 7.1% |
Adjusted beta | 1.02 | 1.13 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 12.20% | 15.00% |
Tax rate | 10.50% | 22.70% |
Debt/Equity ratio | 0.39 | 0.39 |
Cost of debt | 5.00% | 5.00% |
After-tax WACC | 10.0% | 11.9% |
Selected WACC | 10.9% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for 4009.SR:
cost_of_equity (13.60%) = risk_free_rate (6.15%) + equity_risk_premium (6.60%) * adjusted_beta (1.02) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.